PTEN promoter is methylated in a proportion of invasive breast cancers

International Journal of Cancer. Journal International Du Cancer
Salma KhanShikha Bose

Abstract

The PTEN protein is a negative regulator of the Akt pathway, leading to suppression of apoptosis and increased cell survival. Its role as a tumor-suppressor gene has been adequately substantiated, and homozygous mutations have been demonstrated in familial and sporadic cancers. In breast cancers, expression of PTEN protein is lost/reduced in 38% of cases. Somatic mutations are, however, rarely found. Our study was therefore designed to determine if differential methylation of the PTEN promoter region has a role in the transcriptional inactivation of the gene in invasive breast carcinomas. A total of 44 samples of invasive human breast cancer, 5 breast cancer cell lines and 16 samples of normal human breast tissue from young and elderly women were studied for methylation of the PTEN promoter by methylation-specific PCR and PTEN protein expression by immunohistochemistry. PTEN methylation occurred in 34% of breast cancers, and 60% of these samples were associated with loss of PTEN protein. Analyzed from a different perspective, 34% of breast cancers had reduced expression of PTEN and 60% had a methylated PTEN promoter. None of the breast cancer cell lines and normal breast tissues showed methylation. In summary, methylation of th...Continue Reading

References

Aug 11, 1994·Nucleic Acids Research·S J ClarkM Frommer
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Jun 10, 1998·Oncogene·E M DuerrA von Deimling
Jul 14, 1998·Nature Genetics·C Eng, M Peacocke
Feb 13, 1999·Nature Genetics·P A Jones, P W Laird
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·K PodsypaninaR Parsons
Mar 10, 1999·British Journal of Cancer·D FreihoffR K Schmutzler
May 4, 1999·Trends in Cell Biology·T Maehama, J E Dixon
Sep 25, 1999·Science·A Di CristofanoP P Pandolfi
Mar 24, 2000·Trends in Genetics : TIG·S B Baylin, J G Herman
Apr 6, 2000·Journal of the National Cancer Institute·M EstellerJ G Herman
Jun 8, 2000·Journal of the National Cancer Institute·I U Ali
Jan 10, 2001·International Journal of Cancer. Journal International Du Cancer·H B SalvesenS Das
Mar 5, 2002·American Journal of Human Genetics·Kristin A Waite, Charis Eng
Mar 14, 2002·The American Journal of Pathology·Michele A ZysmanBharati Bapat
Mar 16, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Young-Hwa KangWoo Ho Kim
Mar 22, 2002·Biochemical and Biophysical Research Communications·Xiaoyang ShengW K Alfred Yung
Apr 20, 2002·Virchows Archiv : an International Journal of Pathology·Kiyoshi SatoStephen J Meltzer
Jun 11, 2002·Human Pathology·Shikha BoseRamon Parsons

❮ Previous
Next ❯

Citations

Aug 22, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Rebecca A Hinshelwood, Susan J Clark
Dec 21, 2010·Breast Cancer Research and Treatment·Nguyen Thi Thuy PhuongKeon Wook Kang
Aug 7, 2012·Journal of Mammary Gland Biology and Neoplasia·Justin Cidado, Ben Ho Park
Mar 20, 2010·Medical Oncology·Vallian SadeqTavassoli Manoochehr
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
Sep 4, 2007·Breast Cancer Research : BCR·Weiwei FengYinhua Yu
Oct 6, 2010·Breast Cancer Research : BCR·Naiara G BediagaMarian M de Pancorbo
Sep 11, 2007·Biological & Pharmaceutical Bulletin·Tomohiko Maehama
Aug 31, 2010·Future Oncology·Sílvia Carvalho, Fernando Schmitt
Jan 24, 2006·American Journal of Veterinary Research·Yutaka KanaeMasanobu Hayashi
Nov 13, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Enders K O NgAva Kwong
Dec 4, 2013·European Journal of Pharmacology·Katarzyna Lubecka-PietruszewskaKrystyna Fabianowska-Majewska
Jan 14, 2012·Expert Opinion on Therapeutic Targets·Chandra Bartholomeusz, Ana Maria Gonzalez-Angulo
Oct 28, 2016·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Sarah SiddiquiSyed Akhtar Husain
Dec 1, 2010·Clinical Epigenetics·Anatoly V Lichtenstein
Jan 18, 2011·Trends in Pharmacological Sciences·Nick R Leslie, Michelangelo Foti
Dec 31, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kheirollah YariZohreh Rahimi
Apr 2, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Mohammad A Alzohairy
Nov 10, 2005·Clinical Breast Cancer·Funda Meric-Bernstam, Francisco J Esteva
Dec 18, 2007·Research in Veterinary Science·Changwei QiuLei Wang
Nov 13, 2007·Biochimica Et Biophysica Acta·Romina MaroneMatthias P Wymann
Jan 16, 2013·International Journal of Cancer. Journal International Du Cancer·Natalie JonesNicolas Sevenet
Jan 28, 2010·Histopathology·Tove KirkegaardJohn M S Bartlett
Feb 24, 2010·Cancer Science·Dong Sun KimJae Yong Park
Aug 5, 2014·Advances in Biological Regulation·Ludovica CiuffredaMichele Milella
Aug 5, 2014·Epigenetics : Official Journal of the DNA Methylation Society·Breezy M LindqvistTorbjörn K Nilsson
Aug 26, 2014·Journal of Cancer Research and Clinical Oncology·Hui Jun LimJia-Lin Yang
Mar 13, 2015·Frontiers in Oncology·Michele MilellaLudovica Ciuffreda
Mar 2, 2016·PLoS Computational Biology·Beata HatTomasz Lipniacki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis